Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs midazolam for ICU sedation in patients with renal insufficiency
ChiCTR2000039513Phase 4Recruiting
- Sponsor
- Yancheng First People's Hospital
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam and midazolam in acute kidney failure (AKF) and chronic kidney disease (CKD) (2 arms), sponsored by Yancheng First People's Hospital. Primary endpoint: eGFR / creatinine clearance rate. Started Oct 2020; status: recruiting.
02
Drugs
remimazolammidazolam
03
Conditions
acute kidney failure (AKF)chronic kidney disease (CKD)
Beyond the preview
Go deeper on ChiCTR2000039513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039513.